Invention Grant
US08623383B2 Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae
有权
重组抗原用于诊断和预防点状发热立克次体
- Patent Title: Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae
- Patent Title (中): 重组抗原用于诊断和预防点状发热立克次体
-
Application No.: US12480290Application Date: 2009-06-08
-
Publication No.: US08623383B2Publication Date: 2014-01-07
- Inventor: Wei-Mei Ching
- Applicant: Wei-Mei Ching
- Applicant Address: US DC Washington
- Assignee: The United States of America as represented by the Secretary of the Navy
- Current Assignee: The United States of America as represented by the Secretary of the Navy
- Current Assignee Address: US DC Washington
- Agent Ning Yang; Albert M. Churilla; Joseph K. Hemby
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61K39/00 ; A61K38/00 ; C07K1/00 ; G01N33/554 ; G01N33/53
Abstract:
The invention relates to the construction of recombinant, immunodominant polypeptides against spotted fever group Rickettsia. The invention also relates to a method for the use of the recombinant proteins, either singly or in combination, in detection and diagnostic assays of spotted fever. The proteins can also be used to induce immune response against spotted fever group Rickettsia.
Public/Granted literature
- US20090304731A1 RECOMBINANT ANTIGENS FOR DIAGNOSIS AND PREVENTION OF SPOTTED FEVER RICKETTSIAE Public/Granted day:2009-12-10
Information query
